Serial Number | 88918443 |
Word Mark | ZILBRYSQ ZILUCOPLAN |
Filing Date | Friday, May 15, 2020 |
Status | 606 - ABANDONED - NO STATEMENT OF USE FILED |
Status Date | Monday, June 28, 2021 |
Registration Number | 0000000 |
Registration Date | NOT AVAILABLE |
Mark Drawing | 5000 - Drawing with word(s) / letter(s) / number(s) in Stylized form |
Published for Opposition Date | Tuesday, September 29, 2020 |
Indication of Colors claimed | The colors gray, blue, orange, and red are claimed as features of the mark. |
Disclaimer with Predetermined Text | "ZILUCOPLAN" |
Description of Mark | The mark consists of the word "ZILUCOPLAN" in gray under the word "ZILBRYSQ", where the letters "ZILBRYS" of "ZILBRYSQ" are in a blue font and letter "Q" fades from orange to red to blue in a clockwise direction starting from the bottom of the "Q" and ending at the tail of the "Q". |
Goods and Services | Pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory disorder, a wound, a burn, an autoimmune disorder, a pulmonary disorder, a cardiovascular disorder, a neurological disorder, a kidney-related disorder, a diabetes-related disorder, an ocular disorder, and a pregnancy-related disorder; Pharmaceutical preparations, for human use, for the prevention and treatment of disorders of metabolism, the nervous system, the immune system, the cardio-vascular system, the respiratory system, the musculo-skeletal system, and the genitourinary system; Pharmaceutical preparations for the treatment of fibrotic and inflammatory disorders; Pharmaceutical preparations for use in dermatology, nephrology, hepatology, rheumatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for gastroenterological disorders; Pharmaceutical preparations as anti-viral, anti-bacterial, or anti-fungal agents, all of the foregoing containing Zilucoplan |
Goods and Services | Syringes for injections; Syringes for medical purposes; Syringes for medical purposes sold empty which may be filled with pharmaceutical preparations, for human use, for the prevention and treatment of paroxysmal nocturnal hemoglobinuria, myasthenia gravis, an inflammatory indication, a wound, a burn, an autoimmune indication, a pulmonary indication, a cardiovascular indication, a neurological indication, a kidney-related indication, a diabetes-related indication, an ocular indication, and a pregnancy-related indication |
Translation of Words in Mark | The wording "ZILBRYSQ ZILUCOPLAN" has no meaning in a foreign language. |
International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
US Class Codes | 006, 018, 044, 046, 051, 052 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, May 30, 2020 |
Primary Code | 005 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
US Class Codes | 026, 039, 044 |
Class Status Code | 6 - Active |
Class Status Date | Saturday, May 30, 2020 |
Primary Code | 010 |
First Use Anywhere Date | NOT AVAILABLE |
First Use In Commerce Date | NOT AVAILABLE |
Party Name | Ra Pharmaceuticals, Inc. |
Party Type | 20 - Owner at Publication |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02140 |
Party Name | Ra Pharmaceuticals, Inc. |
Party Type | 10 - Original Applicant |
Legal Entity Type | 03 - Corporation |
Address | Cambridge, MA 02140 |
Event Date | Event Description |
Monday, June 28, 2021 | ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED |
Monday, June 28, 2021 | ABANDONMENT - NO USE STATEMENT FILED |
Tuesday, November 24, 2020 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Tuesday, September 29, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, September 29, 2020 | PUBLISHED FOR OPPOSITION |
Wednesday, September 9, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, September 8, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Tuesday, September 1, 2020 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
Tuesday, September 1, 2020 | ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED |
Tuesday, September 1, 2020 | TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED |
Tuesday, August 25, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, August 25, 2020 | EXAMINER'S AMENDMENT ENTERED |
Tuesday, August 25, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Tuesday, August 25, 2020 | EXAMINERS AMENDMENT E-MAILED |
Tuesday, August 25, 2020 | EXAMINERS AMENDMENT -WRITTEN |
Monday, August 24, 2020 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Wednesday, August 19, 2020 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
Wednesday, August 19, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Tuesday, August 4, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Tuesday, August 4, 2020 | EXAMINER'S AMENDMENT ENTERED |
Tuesday, August 4, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Tuesday, August 4, 2020 | EXAMINERS AMENDMENT E-MAILED |
Tuesday, August 4, 2020 | EXAMINERS AMENDMENT -WRITTEN |
Tuesday, July 28, 2020 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Wednesday, July 22, 2020 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
Wednesday, July 8, 2020 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
Wednesday, July 8, 2020 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Monday, June 22, 2020 | ASSIGNED TO LIE |
Thursday, June 18, 2020 | APPROVED FOR PUB - PRINCIPAL REGISTER |
Thursday, June 18, 2020 | EXAMINER'S AMENDMENT ENTERED |
Thursday, June 18, 2020 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
Thursday, June 18, 2020 | EXAMINERS AMENDMENT E-MAILED |
Thursday, June 18, 2020 | EXAMINERS AMENDMENT -WRITTEN |
Thursday, June 18, 2020 | ASSIGNED TO EXAMINER |
Saturday, May 30, 2020 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM |
Tuesday, May 19, 2020 | NEW APPLICATION ENTERED IN TRAM |